SCPC Applauds FDA Commissioner Gottlieb’s Comments Saying PBMs Complicit in “Kabuki Drug-Pricing Constructs” and “Rigged Payment Scheme”
Washington, DC — The Senior Care Pharmacy Coalition (SCPC) today praised Federal Drug Administration (FDA) Commissioner Scott Gottlieb’s pointed comments at an annual conference of health insurers in which he charged that pharmacy benefit manager (PBM) middlemen are complicit in “Kabuki drug pricing constructs” that expose consumers to high costs and discourage needed competition.
“SCPC strongly supports Commissioner Gottlieb’s comments today, and he is simply speaking the truth about PBM duplicity and deception at a time when consumers, lawmakers and regulators are demanding answers about high drug cost culpability,” stated Alan G. Rosenbloom, President and CEO of SCPC, the only Washington-based organization exclusively representing the interests of long-term care (LTC) pharmacies and the patients they serve.
“Commissioner Gottlieb is precisely correct that consumers shouldn’t have to pay more when the primary purpose is to help subsidize rebates paid to a long list of supply chain intermediaries,” Rosenbloom continued.
The FDA Commissioner noted that the top three pharmacy benefit managers — CVS, UnitedHealth Group Inc. and Express Scripts — control more than two-thirds of their market while Rosenbloom noted that for seniors living in the nation’s long term care (LTC) facilities, and served by LTC pharmacies, this percentage jumps to more than 90 percent.
Rosenbloom said the oligopolistic, anti-competitive environment and preponderance of new PBM “pharmacy fees,” “payment adjustments,” and other clawbacks imposed on LTC pharmacies have accelerated dramatically in just the past few years, and ultimately have a negative impact on seniors. These practices have rightfully drawn fresh scrutiny from the Centers for Medicare & Medicaid Services (CMS).
“Any 21st Century business model premised upon hiding facts from consumers and claiming it their right to make secret deals behind closed doors is, and should be, a target for federal reform,” Rosenbloom concluded. “PBMs — like other links in the supply chain — must justify their existence to the consumers who depend upon them, and to taxpayers who fund Medicare.”
####
The SCPC is the national association for independent LTC pharmacies. Our member pharmacies provide care and services to patients in LTC facilities across the country occupying approximately 675,000 beds. Visit seniorcarepharmacies.org to learn more.
Recent Posts
-
Rep. Beth Van Duyne: Congress can save seniors’ access to medications before it’s too late
Seniors in nursing homes across the country depend on round-the-clock care and medications, perhaps more than any other American patient population. In turn, the nursing homes and assisted living facilities that care for them depend on a small number of specialized long-term care (LTC) pharmacies to ensure their patients have access to the prescription meds they need.
-
Bill Aims to Offset Reimbursement Losses for Long-Term Care Pharmacies Catering to Nursing Homes
Starting in January, falling prices for costly drugs may strain long-term care pharmacies, but proposed legislation backed by advocacy groups aims to subsidize some of this loss. And nursing home advocacy groups are among those urging Congress to pass the Preserving Patient Access to Long-Term Care Pharmacies Act.
-
Drug pricing policy could jeopardize long-term care pharmacies, leaders contend
Senior living and care leaders have joined a coalition calling attention to a policy fix they say would address unintended consequences of Medicare Part D price negotiations that could shutter long-term care pharmacies.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.